The successful use of minocycline in pyoderma gangrenosum—a report of seven cases and review of the literature
暂无分享,去创建一个
[1] J. Bonnetblanc,et al. [Pyoderma gangrenosum and vasculitis. Pathogenic discussion apropos of 3 cases]. , 1987, Annales de dermatologie et de venereologie.
[2] F. Goldstein,et al. Intralesional steroid therapy of pyoderma gangrenosum. , 1985, Journal of clinical gastroenterology.
[3] C. Vickers,et al. Pyoderma gangrenosum treated with cyclosporin A , 1985, The British journal of dermatology.
[4] R. S. Basler. Minocycline-related hyperpigmentation. , 1985, Archives of dermatology.
[5] F. Malkinson,et al. Pyoderma Gangrenosum: Response to Cyclophosphamide Therapy , 1983 .
[6] M. Davies,et al. Pyoderma gangrenosum: successful treatment with minocycline , 1981, Clinical and experimental dermatology.
[7] Walters,et al. Tetracycline and benign intracranial hypertension: report of five cases. , 1981, British medical journal.
[8] G. Nuki,et al. Pyoderma Gangrenosum: CLINICAL AND LABORATORY FINDINGS IN 15 PATIENTS WITH SPECIAL REFERENCE TO POLYARTHRITIS , 1980, Medicine.
[9] P. Holt. The current status of pyoderma gangrenosum , 1979, Clinical and experimental dermatology.
[10] Bergfeld Wf,et al. Pyoderma gangrenosum responsive to minocycline hydrochloride. , 1978 .
[11] L. Hovelius,et al. Report of Five Cases , 1977 .
[12] H. Valdimarsson,et al. (33) Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion , 1976, British Journal of Dermatology.
[13] D. Rosenthal,et al. Pyoderma Gangrenosum and rheumatoid arthritis. , 1975, Archives of dermatology.
[14] Dantzig Pi. Letter: Pyoderma gangrenosum. , 1975 .
[15] R. Couch,et al. Effects of tetracycline on leukotaxis. , 1974, The Journal of infectious diseases.
[16] E. Schöpf,et al. [Azathioprine treatment of ulcerative dermatitis (pyoderma gangrenosum)]. , 1969, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[17] I. Sluis. Two Cases of Pyoderma (Ecthyma) Gangraenosum Associated with the Presence of an Abnormal Serumprotein (β2A-paraprotein) , 1966 .
[18] A. Lorincz,et al. Sulfapyridine and sulfone type drugs in dermatology. , 1962, Archives of dermatology.
[19] G. Percival. PYODERMA GANGRENOSUM: THE HISTOLOGY OF THE PRIMARY LESION. * , 1957, The British journal of dermatology.
[20] H. Perry,et al. Pyoderma Gangrenosum: A Clinical Study of Nineteen Cases , 1957 .
[21] B. Russell. PHAGEDENIC AND GANGRENOUS ULCERATION OF THE SKIN COMPLICATING ULCERATIVE COLITIS (PHAGEDENA GEOMETRICUM) , 1950 .
[22] F. Sagher,et al. PHAGEDENIC ULCER (PYODERMA GANGRAENOSUM): TREATMENT WITH SULFAPYRIDINE POWDER AND MOIST CHAMBER THERAPY , 1943 .
[23] S. S. Greenbaum. PHAGEDAENA GEOMETRICA (BROCQ): INOCULATION STUDIES WITH VIABLE BACTERIA CULTURED FROM LESIONS OF PHAGEDAENA GEOMETRICA (BROCQ) (CHRONIC BURROWING ULCER AND PYODERMA GANGRAENOSUM) , 1941 .
[24] A. L. Weiner. PYODERMA GANGRAENOSUM TREATED WITH SULFANILAMIDE: REPORT OF A CASE , 1940 .
[25] L. Brunsting,et al. PYODERMA (ECHTHYMA) GANGRENOSUM: CLINICAL AND EXPERIMENTAL OBSERVATIONS IN FIVE CASES OCCURRING IN ADULTS , 1930 .